Cargando…

Decreased levels of serum platelet-activating factor acetylhydrolase in patients with rheumatic diseases

PAF is a potent inflammatory compound known to stimulate the release of various cytokines involved in rheumatic diseases. Elevated blood PAF levels are reported in these patients. We report that serum PAF acetylhydrolase activity (AHA) levels are decreased in patients with rheumatoid arthritis or os...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vergne, P., Praloran, V., Treves, R., Denizot, Y.
Formato:	Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 1997
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2365831/ https://www.ncbi.nlm.nih.gov/pubmed/18472827 http://dx.doi.org/10.1080/09629359791758

Ejemplares similares

Platelet-activating factor acetylhydrolase and haemophagocytosis in the sepsis syndrome.
por: Trimoreau, F, et al.
Publicado: (2000)

Elevated plasma phospholipase A2 and platelet-activating factor acetylhydrolase activity in colorectal cancer.
por: Denizot, Yves, et al.
Publicado: (2004)

Platelets and platelet-activating factor acetylhydrolase in septic patients
por: Ruβwurm, S, et al.
Publicado: (1999)

Ezetimibe Monotherapy Reduces Serum Levels of Platelet-Activating Factor Acetylhydrolase in Patients With Dyslipidemia
por: Tano, Kanako, et al.
Publicado: (2019)

Platelet-activating factor acetylhydrolase in primary antiphospholipid syndrome
por: Ames, Paul R. J., et al.
Publicado: (2018)

Decrease of Plasma Platelet-Activating Factor Acetylhydrolase Activity in Lipopolysaccharide Induced Mongolian Gerbil Sepsis Model
por: Yang, Junwei, et al.
Publicado: (2010)

Platelet‐activating factor acetylhydrolase: A biomarker in Hymenoptera venom allergy?
por: Bilò, Maria Beatrice, et al.
Publicado: (2021)

Serum Activity of Platelet-Activating Factor Acetylhydrolase Is a Potential Clinical Marker for Leptospirosis Pulmonary Hemorrhage
por: Yang, Junwei, et al.
Publicado: (2009)

Platelet-activating factor acetylhydrolase and transacetylase activities in human aorta and mammary artery
por: Tsoukatos, Demokritos C., et al.
Publicado: (2008)

Relationship between platelet activating factor acetylhydrolase activity and apolipoprotein B levels in patients with peanut allergy
por: Perelman, Boris, et al.
Publicado: (2014)

Clinical application of elevated platelet-activating factor acetylhydrolase in patients with hepatitis B
por: Feng, Limin, et al.
Publicado: (2014)

Effect of platelet-activating factor on the growth of human erythroid and myeloid CD34+ progenitors.
por: Dupuis, F, et al.
Publicado: (1998)

Exploring the plasmatic platelet-activating factor acetylhydrolase activity in patients with anti-phospholipid antibodies
por: Fabris, Martina, et al.
Publicado: (2017)

Elevated plasma platelet-activating factor acetylhydrolase activity and its relationship to the presence of coronary artery disease(*)
por: Samsamshariat, Saedziaaldin, et al.
Publicado: (2011)

Bacterial Clearance Is Improved in Septic Mice by Platelet-Activating Factor-Acetylhydrolase (PAF-AH) Administration
por: Teixeira-da-Cunha, Mariana G. A., et al.
Publicado: (2013)

PAF and Haematopoiesis. I. 5-Fluoro-Uracil Induces PAF Production in Haematopoietic Organs of Rats
por: Denizot, Y., et al.
Publicado: (1994)

Biological Role of Trichoderma harzianum-Derived Platelet-Activating Factor Acetylhydrolase (PAF-AH) on Stress Response and Antagonism
por: Yu, Chuanjin, et al.
Publicado: (2014)

The prevalence of platelet activating factor acetylhydrolase single nucleotide polymorphisms in relationship to necrotizing enterocolitis in Northwest Louisiana infants
por: Sankararaman, Senthilkumar, et al.
Publicado: (2013)

Class A CpG Oligonucleotide Priming Rescues Mice from Septic Shock via Activation of Platelet-Activating Factor Acetylhydrolase
por: Yamamoto, Yoshinari, et al.
Publicado: (2017)

MicroRNA-144 suppresses cholangiocarcinoma cell proliferation and invasion through targeting platelet activating factor acetylhydrolase isoform 1b
por: Yang, Rui, et al.
Publicado: (2014)

Tumour necrosis factor-alpha (TNFα) stimulates the growth of human bone marrow stromal cells
por: Rougier, F., et al.
Publicado: (1997)

Incorporation and effect of arachidonic acid on the growth of human myeloma cell lines.
por: Desplat, V, et al.
Publicado: (1999)

Platelet-Activating Factor Acetylhydrolase Expression in BRCA1 Mutant Ovarian Cancer as a Protective Factor and Potential Negative Regulator of the Wnt Signaling Pathway
por: Liao, Yue, et al.
Publicado: (2021)

Lipoprotein-associated phospholipase A(2 )(Lp-PLA(2)) activity, platelet-activating factor acetylhydrolase (PAF-AH) in leukocytes and body composition in healthy adults
por: Detopoulou, Paraskevi, et al.
Publicado: (2009)

cDNA Cloning and Expression Pattern of Homolog of Alpha Subunit of Platelet-Activating Factor Acetylhydrolase Ib from the Chinese Oak Silkworm, Antheraea pernyi
por: Li, Yu-Ping, et al.
Publicado: (2011)

Arachidonic acid and freshly isolated human bone marrow mononuclear cells.
por: Denizot, Y, et al.
Publicado: (1999)

Effects of lipoxygenase metabolites of arachidonic acid on the growth of human mononuclear marrow cells and marrow stromal cell cultures.
por: Desplat, V, et al.
Publicado: (1998)

Molecular Model of Plasma PAF Acetylhydrolase-Lipoprotein Association: Insights from the Structure
por: Srinivasan, Prabhavathi, et al.
Publicado: (2010)

Effect of the R92H and A379V genotypes of platelet-activating factor acetylhydrolase on its enzyme activity, oxidative stress and metabolic profile in Chinese women with polycystic ovary syndrome
por: Zhang, Renjiao, et al.
Publicado: (2017)

Clinical significance of plasma PAF acetylhydrolase activity measurements as a biomarker of anaphylaxis: Cross-sectional study
por: Piwowarek, Krzysztof Łukasz, et al.
Publicado: (2021)

Functional Consequences of Mutations and Polymorphisms in the Coding Region of the PAF Acetylhydrolase (PAF-AH) Gene
por: Stafforini, Diana M.
Publicado: (2009)

The Platelet-to-Lymphocyte Ratio as an Inflammatory Marker in Rheumatic Diseases
por: Gasparyan, Armen Yuri, et al.
Publicado: (2019)

Expression of a splice variant of the platelet-activating factor receptor transcript 2 in various human cancer cell lines.
por: Youlyouz, Ibtissam, et al.
Publicado: (2002)

Host-Induced Gene Silencing of a Sclerotinia sclerotiorum oxaloacetate acetylhydrolase Using Bean Pod Mottle Virus as a Vehicle Reduces Disease on Soybean
por: McCaghey, Megan, et al.
Publicado: (2021)

No evidence for a putative involvement of platelet-activating factor in systemic lupus erythematosus without active nephritis.
por: Denizot, Yves, et al.
Publicado: (2003)

THE OCCURRENCE OF LEUCOCYTE-PLATELET THROMBOSIS IN RHEUMATIC CARDITIS
por: Stetson, Chandler A.
Publicado: (1951)

Vascular endothelial growth factor levels and rheumatic diseases of the elderly
por: Smets, Perrine, et al.
Publicado: (2016)

Platelet-activating factor levels of serum and gingival crevicular fluid in nonsmoking patients with periodontitis and/or coronary heart disease
por: Chen, Hui, et al.
Publicado: (2009)

IL-35, TNF-α, BAFF, and VEGF serum levels in patients with different rheumatic diseases
por: Wojdasiewicz, Piotr, et al.
Publicado: (2019)

Plasma macrophage colony-stimulating factor levels during cardiopulmonary bypass with extracorporeal circulation
por: Denizot, Y., et al.
Publicado: (1996)

Cannot write session to /tmp/vufind_sessions/sess_hs9g9s9qjk08dakquathfstarl